BRD-8000.3
Product Specifications
UNSPSC Description
BRD-8000.3, as a specific EfpA inhibitor, is a narrow-spectrum, bactericidal antimycobacterial agent with good wild-type activity. BRD-8000.3 can be used for the research of tuberculosis[1].
Target Antigen
Antibiotic
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/brd-8000-3.html
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C([C@@H]1C(C)(C)[C@H]1/C=C(C)\C)NC2=NC(Br)=C(C3=NC=CC=N3)C=C2
Molecular Weight
401.30
References & Citations
[1]Johnson EO, et al. Large-Scale Chemical-Genetic Strategy Enables the Design of Antimicrobial Combination Chemotherapy in Mycobacteria. ACS Infect Dis. 2020;6(1):56-63.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-141715/BRD-8000-3-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-141715/BRD-8000-3-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
2365504-95-4
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
JL16597-01 48 Tests
Human ProProtein Convertase Subtilisin/Kexin Type 1 (PCSK1) ELISA Kit
Ask
View Details JL16597-02 96 Tests
Human ProProtein Convertase Subtilisin/Kexin Type 1 (PCSK1) ELISA Kit
Ask
View Details